Recombinate

List of products in the National Drug Code with proprietary name recombinate. This medication is used to control and prevent bleeding episodes in people with low levels of factor VIII (hemophilia A). It is also used in these patients before surgery to prevent bleeding. People with low factor VIII levels are at risk for bleeding longer after an injury/surgery and for bleeding inside the body (especially into the joints and muscles). This product contains a man-made form of factor VIII, also called antihemophilic factor. This product is used to temporarily replace the missing factor VIII, a protein (clotting factor) that is normally in the blood, so that the blood can clot and the bleeding can stop. This medication should not be used to treat von Willebrand disease.

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Labeler Name Product Type
0944-2841Recombinate Antihemophilic Factor RecombinantKitTakeda Pharmaceuticals America, Inc.Plasma Derivative
0944-2842Recombinate Antihemophilic Factor RecombinantKitTakeda Pharmaceuticals America, Inc.Plasma Derivative
0944-2843Recombinate Antihemophilic Factor RecombinantKitTakeda Pharmaceuticals America, Inc.Plasma Derivative
0944-2844Recombinate Antihemophilic Factor RecombinantKitTakeda Pharmaceuticals America, Inc.Plasma Derivative
0944-2845Recombinate Antihemophilic Factor RecombinantKitTakeda Pharmaceuticals America, Inc.Plasma Derivative